Coxitor (Etoricoxib) is a non-steroidal anti-inflammatory drug (NSAID) that exhibits anti-inflammatory, analgesic, and antipyretic activities. It is a potent, orally active, and highly selective cyclooxygenase-2 (COX-2) inhibitor within and above the clinical dose range. COX-2 is primarily responsible for the synthesis of prostanoid mediators of pain, inflammation, and fever; therefore, selective inhibition by Etoricoxib effectively reduces these clinical signs and symptoms.
This selective action is associated with decreased gastrointestinal toxicity compared to non-selective NSAIDs and does not significantly affect platelet function.
| Product Name | Coxitor |
| Generic Name | Etoricoxib INN |
| Formulation | Coxitor 30 Tablet: Each film-coated tablet contains Etoricoxib INN 30 mg. Coxitor 60 Tablet: Each film-coated tablet contains Etoricoxib INN 60 mg. Coxitor 90 Tablet: Each film-coated tablet contains Etoricoxib INN 90 mg. Coxitor 120 Tablet: Each film-coated tablet contains Etoricoxib INN 120 mg. |
| Available Pack Size | Coxitor 30 mg: 5×10’s Coxitor 60 mg: 5×10’s Coxitor 90mg: 4×10’s Coxitor 120 mg: 3×10’s |
| Available Strength | Etoricoxib INN 30,60,90 & 120 mg tablet. |